W Ageno, AS Gallus, A Wittkowsky, M Crowther… - Chest, 2012 - Elsevier
Background The objective of this article is to summarize the published literature concerning the pharmacokinetics and pharmacodynamics of oral anticoagulant drugs that are currently …
JG Andrade, M Aguilar, C Atzema, A Bell… - Canadian Journal of …, 2020 - Elsevier
Abstract The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines program was developed to aid clinicians in the management of these complex patients, as …
JF Meschia, C Bushnell, B Boden-Albala, LT Braun… - Stroke, 2014 - Am Heart Assoc
The aim of this updated statement is to provide comprehensive and timely evidence-based recommendations on the prevention of stroke among individuals who have not previously …
Background and Purpose—This guideline provides an overview of the evidence on established and emerging risk factors for stroke to provide evidence-based …
J Ansell, J Hirsh, E Hylek, A Jacobson, M Crowther… - Chest, 2008 - Elsevier
This article concerning the pharmacokinetics and pharmacodynamics of vitamin K antagonists (VKAs) is part of the American College of Chest Physicians Evidence-Based …
This article discusses the perioperative management of antithrombotic therapy and is part of the American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th …
DE Singer, GW Albers, JE Dalen, MC Fang, AS Go… - Chest, 2008 - Elsevier
This chapter about antithrombotic therapy in atrial fibrillation (AF) is part of the American College of Chest Physicians Evidence-Based Guidelines Clinical Practice Guidelines (8th …
Background and Purpose—Warfarin is the most effective stroke prevention medication for high-risk individuals with atrial fibrillation, yet it is often underused. This study examined the …
Importance Antithrombotic therapies are known to prevent stroke for patients with atrial fibrillation (AF) but are often underused in community practice. Objectives To examine the …